PTGX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,501,869.23

Protagonist Therapeutics Insider Trading History Chart

Protagonist Therapeutics Share Price & Price History

^$47.02

▲ +1.37 (3.00%)

As of 09/13/2024 01:00 AM ET

Days: 30 | 90 | 365

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Protagonist Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Asif Ali	CFO	Sell	14,203	$44.49	$631,891.47	34,960
9/10/2024	William D Waddill	Director	Sell	8,000	$45.00	$360,000.00	12,000
7/24/2024	William D Waddill	Director	Sell	8,000	$40.00	$320,000.00	12,000
6/7/2024	Dinsesh V. Patel	CEO	Sell	35,000	$35.19	$1,231,650.00	515,415
6/7/2024	William D Waddill	Director	Sell	8,000	$35.00	$280,000.00	12,000
4/18/2024	Asif Ali	CFO	Sell	1,234	$25.11	$30,985.74	37,163
4/1/2024	Dinsesh V. Patel	CEO	Sell	25,000	$28.31	$707,750.00	549,590
3/1/2024	Asif Ali	CFO	Sell	14,248	$32.24	$459,355.52	38,397
3/1/2024	Dinsesh V. Patel	CEO	Sell	30,000	$31.62	$948,600.00	574,590
3/1/2024	William D Waddill	Director	Sell	12,975	$31.34	$406,636.50	12,000
1/9/2024	Suneel Gupta	Insider	Sell	5,000	$25.00	$125,000.00	187,567
12/21/2021	Dinsesh V. Patel	CEO	Sell	15,000	$32.14	$482,100.00

Turn Smartphones Into “Earnphones”?

From Mode Mobile | Ad

High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportunity.

Claim Exclusive 100% Bonus: $0.25/Share

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

98.63% of Protagonist Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protagonist Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2024	Perceptive Advisors LLC	1,268,735	$43.96M	1.0%	+27.6%	2.154%
8/16/2024	Northwestern Mutual Wealth Management Co.	157,788	$5.47M	0.0%	N/A	0.268%
8/16/2024	Algert Global LLC	152,079	$5.27M	0.2%	+2.9%	0.258%
8/16/2024	Driehaus Capital Management LLC	556,835	$19.29M	0.2%	-0.7%	0.945%
8/15/2024	The Manufacturers Life Insurance Company	114,406	$3.96M	0.0%	+27.6%	0.194%
8/15/2024	Millennium Management LLC	958,283	$33.21M	0.0%	+2,135.6%	1.627%
8/15/2024	Dark Forest Capital Management LP	60,962	$2.11M	0.4%	N/A	0.104%
8/15/2024	AQR Capital Management LLC	25,055	$0.87M	0.0%	-69.1%	0.043%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	14,556	$0.50M	0.1%	N/A	0.025%
8/14/2024	Squarepoint Ops LLC	9,823	$0.34M	0.0%	N/A	0.017%
8/14/2024	Point72 Asset Management L.P.	909,734	$31.52M	0.1%	-24.2%	1.545%
8/14/2024	Cubist Systematic Strategies LLC	84,202	$2.92M	0.0%	+1,304.5%	0.143%
8/14/2024	Point72 DIFC Ltd	4,415	$0.15M	0.0%	N/A	0.007%
8/14/2024	Marshall Wace LLP	572,177	$19.83M	0.0%	-41.4%	0.971%
8/14/2024	Farallon Capital Management LLC	5,840,773	$202.38M	1.0%	+1.8%	9.916%
8/14/2024	ProShare Advisors LLC	11,270	$0.39M	0.0%	-21.4%	0.019%
8/14/2024	Profund Advisors LLC	14,529	$0.50M	0.0%	-61.2%	0.025%
8/12/2024	Inspire Investing LLC	10,234	$0.36M	0.0%	-17.1%	0.017%
8/12/2024	Seven Eight Capital LP	36,793	$1.28M	0.1%	+426.9%	0.063%
8/12/2024	Hsbc Holdings PLC	7,529	$0.26M	0.0%	-93.3%	0.013%
8/9/2024	Renaissance Technologies LLC	297,467	$10.31M	0.0%	+813.4%	0.507%
8/9/2024	Dimensional Fund Advisors LP	616,172	$21.35M	0.0%	-22.1%	1.051%
8/8/2024	American Century Companies Inc.	27,311	$0.95M	0.0%	-83.0%	0.047%
8/7/2024	Cowen AND Company LLC	1,182,268	$40.97M	1.1%	-24.1%	2.016%
8/6/2024	Quest Partners LLC	2,431	$84K	0.0%	-58.8%	0.004%
8/6/2024	Great Lakes Advisors LLC	93,479	$3.24M	0.0%	-3.8%	0.159%
8/6/2024	Candriam S.C.A.	273,818	$9.49M	0.1%	-23.9%	0.467%
8/5/2024	Arizona State Retirement System	12,236	$0.42M	0.0%	-3.5%	0.021%
8/3/2024	TD Asset Management Inc	148,302	$5.14M	0.0%	+36.7%	0.253%
8/2/2024	Cannon Global Investment Management LLC	69,900	$2.42M	11.2%	N/A	0.119%
7/29/2024	Principal Financial Group Inc.	10,028	$0.35M	0.0%	-30.2%	0.017%
7/26/2024	Bank of New York Mellon Corp	204,299	$7.08M	0.0%	+9.1%	0.348%
7/20/2024	Hennion & Walsh Asset Management Inc.	37,880	$1.31M	0.1%	+8.6%	0.065%
7/12/2024	SG Americas Securities LLC	10,951	$0.38M	0.0%	N/A	0.019%
5/24/2024	Farallon Capital Management LLC	5,738,973	$166.03M	0.7%	+0.1%	9.785%
5/16/2024	California State Teachers Retirement System	47,239	$1.37M	0.0%	-6.3%	0.081%
5/16/2024	Kennedy Capital Management LLC	298,068	$8.62M	0.2%	-2.2%	0.508%
5/16/2024	Kynam Capital Management LP	1,144,242	$33.10M	3.5%	-42.9%	1.951%
5/16/2024	BVF Inc. IL	3,755,990	$108.66M	3.0%	-34.6%	6.404%
5/16/2024	Silvercrest Asset Management Group LLC	188,743	$5.46M	0.0%	+4.6%	0.322%
5/16/2024	Caxton Associates LP	16,047	$0.46M	0.0%	N/A	0.027%
5/15/2024	Bellevue Group AG	19,146	$0.55M	0.0%	-36.2%	0.033%
5/15/2024	Price T Rowe Associates Inc. MD	819,296	$23.70M	0.0%	-0.5%	1.397%
5/15/2024	Lazard Asset Management LLC	2,415	$69K	0.0%	N/A	0.004%
5/15/2024	Affinity Asset Advisors LLC	100,000	$2.89M	0.4%	N/A	0.170%
5/14/2024	CANADA LIFE ASSURANCE Co	9,083	$0.26M	0.0%	+74.2%	0.015%
5/13/2024	Seven Eight Capital LP	6,983	$0.20M	0.0%	N/A	0.012%
5/10/2024	Vanguard Group Inc.	3,192,971	$92.37M	0.0%	+1.2%	5.445%
5/9/2024	State Board of Administration of Florida Retirement System	11,323	$0.33M	0.0%	-30.5%	0.019%
5/8/2024	ProShare Advisors LLC	14,345	$0.42M	0.0%	+9.2%	0.024%
5/8/2024	Russell Investments Group Ltd.	1,216	$35K	0.0%	N/A	0.002%
5/8/2024	Inspire Investing LLC	12,340	$0.36M	0.0%	-26.5%	0.021%
5/7/2024	Sei Investments Co.	41,758	$1.21M	0.0%	+12.2%	0.071%
5/3/2024	GSA Capital Partners LLP	55,359	$1.60M	0.1%	+179.8%	0.094%
5/1/2024	BNP Paribas Financial Markets	47,233	$1.37M	0.0%	-34.3%	0.081%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	29,558	$0.86M	0.0%	-6.9%	0.050%
4/30/2024	Privium Fund Management B.V.	114,024	$3.30M	0.9%	N/A	0.196%
4/30/2024	Allspring Global Investments Holdings LLC	1,970	$57K	0.0%	-22.2%	0.003%
4/29/2024	China Universal Asset Management Co. Ltd.	11,192	$0.32M	0.0%	+67.7%	0.019%
4/18/2024	Allspring Global Investments Holdings LLC	1,970	$57K	0.0%	-22.2%	0.003%
4/17/2024	Hennion & Walsh Asset Management Inc.	34,895	$1.01M	0.1%	+2.5%	0.060%
4/5/2024	Los Angeles Capital Management LLC	30,827	$0.89M	0.0%	+236.8%	0.053%
2/26/2024	Perceptive Advisors LLC	383,260	$8.79M	0.2%	-63.6%	0.664%
2/20/2024	Readystate Asset Management LP	57,206	$1.31M	0.0%	-69.0%	0.098%
2/15/2024	Opaleye Management Inc.	112,700	$2.58M	0.7%	N/A	0.195%
2/15/2024	Birchview Capital LP	48,000	$1.10M	0.9%	+26.3%	0.083%
2/14/2024	ADAR1 Capital Management LLC	200,859	$4.61M	1.6%	N/A	0.348%
2/14/2024	Superstring Capital Management LP	379,143	$8.69M	6.2%	N/A	0.657%
2/14/2024	Kynam Capital Management LP	2,004,875	$45.97M	5.1%	+10.2%	3.476%
2/14/2024	RTW Investments LP	5,315,514	$121.89M	1.9%	-1.8%	9.216%
2/13/2024	Rafferty Asset Management LLC	167,795	$3.85M	0.0%	-52.1%	0.291%
2/12/2024	Hsbc Holdings PLC	119,334	$2.74M	0.0%	-78.5%	0.207%
2/8/2024	Great Lakes Advisors LLC	91,153	$2.09M	0.0%	-35.6%	0.158%
2/7/2024	Gratus Capital LLC	397,571	$9.12M	0.5%	+35.8%	0.689%
2/7/2024	Principal Financial Group Inc.	14,429	$0.33M	0.0%	-3.6%	0.025%
2/7/2024	BNP Paribas Financial Markets	71,898	$1.65M	0.0%	-50.1%	0.125%
2/7/2024	Teacher Retirement System of Texas	10,640	$0.24M	0.0%	-17.9%	0.018%
2/7/2024	E Fund Management Co. Ltd.	8,957	$0.21M	0.0%	-50.2%	0.016%
2/6/2024	Charles Schwab Investment Management Inc.	455,321	$10.44M	0.0%	+3.7%	0.789%
2/6/2024	Los Angeles Capital Management LLC	9,154	$0.21M	0.0%	N/A	0.016%
2/6/2024	Swiss National Bank	90,700	$2.08M	0.0%	-9.8%	0.157%
1/31/2024	Obermeyer Wood Investment Counsel Lllp	12,066	$0.28M	0.0%	-12.5%	0.021%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,338	$0.24M	0.0%	+11.8%	0.018%
1/30/2024	Strs Ohio	2,400	$55K	0.0%	-80.0%	0.004%
1/26/2024	Moody Aldrich Partners LLC	62,327	$1.43M	0.3%	-9.6%	0.108%
1/25/2024	Allspring Global Investments Holdings LLC	2,533	$58K	0.0%	-70.2%	0.004%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	31,759	$0.73M	0.0%	-14.7%	0.055%
1/24/2024	China Universal Asset Management Co. Ltd.	6,675	$0.15M	0.0%	+353.2%	0.012%
12/18/2023	Vanguard Group Inc.	3,228,394	$53.85M	0.0%	+2.6%	5.597%
11/21/2023	Walleye Capital LLC	133,816	$2.23M	0.0%	+209.3%	0.232%
11/15/2023	Kennedy Capital Management LLC	319,534	$5.33M	0.1%	-20.8%	0.554%
11/15/2023	Kynam Capital Management LP	1,818,657	$30.34M	5.0%	+86.5%	3.153%
11/15/2023	Adage Capital Partners GP L.L.C.	700,000	$11.68M	0.0%	-45.9%	1.214%
11/14/2023	683 Capital Management LLC	732,784	$12.22M	1.0%	-10.0%	1.270%
11/14/2023	Braidwell LP	1,109,150	$18.50M	0.6%	N/A	1.923%
11/14/2023	Schonfeld Strategic Advisors LLC	154,098	$2.57M	0.0%	N/A	0.267%
11/14/2023	Profund Advisors LLC	58,716	$0.98M	0.1%	+13.4%	0.102%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	139,494	$2.33M	0.0%	-14.6%	0.242%
11/13/2023	Algert Global LLC	72,830	$1.22M	0.1%	+167.5%	0.126%
11/13/2023	Federated Hermes Inc.	60,234	$1.01M	0.0%	+102.6%	0.104%

Data available starting January 2016

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Today's Range

Now: $47.02

$45.42

$47.15

50 Day Range

MA: $39.76

$34.50

$47.02

52 Week Range

Now: $47.02

$13.72

$47.15

Volume

621,098 shs

Average Volume

763,177 shs

Market Capitalization

$2.77 billion

P/E Ratio

19.27

Dividend Yield

N/A

Beta

2.17

Who are the company insiders with the largest holdings of Protagonist Therapeutics?: Protagonist Therapeutics' top insider investors include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More about top insider investors at Protagonist Therapeutics.
Who are the major institutional investors of Protagonist Therapeutics?: Protagonist Therapeutics' top institutional shareholders include:
Farallon Capital Management LLC — 9.92%
Perceptive Advisors LLC — 2.15%
Cowen AND Company LLC — 2.02%
Millennium Management LLC — 1.63%
Point72 Asset Management L.P. — 1.54%
Dimensional Fund Advisors LP — 1.05%
Learn More about top institutional investors of Protagonist Therapeutics stock.
Which major investors are selling Protagonist Therapeutics stock?: Within the previous quarter, PTGX stock was sold by these institutional investors:
Marshall Wace LLP
Cowen AND Company LLC
Point72 Asset Management L.P.
Dimensional Fund Advisors LP
American Century Companies Inc.
Hsbc Holdings PLC
Candriam S.C.A.
AQR Capital Management LLC
During the previous year, company insiders that have sold Protagonist Therapeutics company stock include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More investors selling Protagonist Therapeutics stock.
Which major investors are buying Protagonist Therapeutics stock?: Within the last quarter, PTGX stock was bought by institutional investors including:
Millennium Management LLC
Perceptive Advisors LLC
Renaissance Technologies LLC
Northwestern Mutual Wealth Management Co.
Farallon Capital Management LLC
Cubist Systematic Strategies LLC
Cannon Global Investment Management LLC
Dark Forest Capital Management LP